PreTect HPV-Proofer: real-time detection and typing of E6/E7 mRNA from carcinogenic human papillomaviruses.
about
Comparison of seven tests for high-grade cervical intraepithelial neoplasia in women with abnormal smears: the Predictors 2 study.Nucleic acid sequence-based amplification assay for human papillomavirus mRNA detection and typing: evidence for DNA amplification.Clinical performance of the PreTect HPV-Proofer E6/E7 mRNA assay in comparison with that of the Hybrid Capture 2 test for identification of women at risk of cervical cancer.MassARRAY spectrometry is more sensitive than PreTect HPV-Proofer and consensus PCR for type-specific detection of high-risk oncogenic human papillomavirus genotypes in cervical cancer.Aptima HPV E6/E7 mRNA test is as sensitive as Hybrid Capture 2 Assay but more specific at detecting cervical precancer and cancerAssessing the detection of human papillomavirus late mRNA in liquid base cytology samples for risk stratification of cervical disease.Presence of High-Risk HPV mRNA in Relation to Future High-Grade Lesions among High-Risk HPV DNA Positive Women with Minor Cytological AbnormalitiesMolecular beacons in diagnosticsHPV detection methods in head and neck cancer.Zinc finger arrays binding human papillomavirus types 16 and 18 genomic DNA: precursors of gene-therapeutics for in-situ reversal of associated cervical neoplasiaA comparison of human papillomavirus genotype-specific DNA and E6/E7 mRNA detection to identify anal precancer among HIV-infected men who have sex with men.Comparing the performance of six human papillomavirus tests in a screening populationCervical cancer screening: from molecular basis to diagnostic practice, going through new technologies.Human papillomavirus DNA and e6/e7 mRNA status in relation to survival of patients treated for cervical squamous cell carcinomaLooking ahead: a case for human papillomavirus testing of self-sampled vaginal specimens as a cervical cancer screening strategy.Clinical performance of human papillomavirus E6 and E7 mRNA testing for high-grade lesions of the cervix.Commercially available assays for multiplex detection of alpha human papillomaviruses.Human papilloma virus (HPV) molecular diagnostics.Molecular beacons: a novel optical diagnostic tool.Cervical cancer screening: on the way to a shift from cytology to full molecular screening.Histopathologic risk factors in oral and oropharyngeal squamous cell carcinoma variants: an update with special reference to HPV-related carcinomas.Human papillomavirus mRNA and DNA testing in women with atypical squamous cells of undetermined significance: A prospective cohort study.Comparison of digene hybrid capture 2, GeneMatrix PapilloScreen, and a PCR sequencing assay in detecting high-risk and probable high-risk oncogenic HPV genotypes in specimens from Korean women.Prospective evaluation of E6/E7 mRNA detection by the NucliSENS Easy Q HPV assay in a stepwise protocol.Performance of ProEx C and PreTect HPV-Proofer E6/E7 mRNA tests in comparison with the hybrid capture 2 HPV DNA test for triaging ASCUS and LSIL cytology.HPV types in cervical cancer tissue in South Africa: A head-to-head comparison by mRNA and DNA tests.Compatible immuno-NASBA LOC device for quantitative detection of waterborne pathogens: design and validation.
P2860
Q30423690-5E80ED5B-D289-4AA6-8802-CC8B6291A994Q33963645-029D1FE9-C68A-4D12-8481-EBD41203B8ADQ34046296-F4E35ECA-8CE5-4E98-9680-71323CD6B5A5Q34205793-FB9FBD13-9EAA-4BF7-9FD1-F3C0A8C0843EQ34596772-6D6A108C-541F-46FC-A614-C776D54471E7Q34806026-83358107-E4CA-4273-B7CE-73C05C613DD1Q35498040-82220348-CF27-4D33-84CB-C16802032BE5Q35975458-839F754D-0A7D-47F5-8527-D8CC97ECC929Q36088064-FB258560-B1A3-465A-9C5D-4C2C434D4CF9Q36437222-6AFF21FA-166B-4DA8-AF49-9B8255703460Q36514226-EE107E07-B33B-41F7-A6FC-AA4037CC1E43Q36663594-04FE34FB-607C-4492-B981-A573A7C1E7B1Q37160475-881C58DA-E81E-47D2-8132-BB85C875391AQ37183629-6671E5CF-AA5B-42BD-8561-27600283DBD0Q37195121-E07BC43A-B889-4AFB-A08E-34CCF94AE565Q37451826-1EB97C28-8A84-4D9F-B92F-B972907119D7Q37800921-DDC20486-ABA9-422C-B812-B943067455BBQ37923517-1C7ED736-EF04-4B42-9B83-9DA71615AF43Q38071908-3728B641-4F57-4A4B-9F02-5FCD065AE7ABQ38180277-35C43CE9-B456-4F08-808C-E170449DA8D1Q38216311-07DD6C8C-11ED-48BF-AB06-58E995857291Q40744991-0536F15A-3AEA-491A-AC5D-6A3ABE9B96B8Q42235610-3A619DF2-99AB-4F56-A77E-A9B05671B9E9Q42278781-1EFEF920-C1CB-40D8-971C-5CC2FC46190DQ43524242-7E45190D-9840-4C7F-9E6D-2327991FD08BQ47321818-CB82B27B-3F51-4AE3-BE53-6320B6D300D4Q51543830-0E6D92DB-864A-4355-94B9-FF97075C6B50
P2860
PreTect HPV-Proofer: real-time detection and typing of E6/E7 mRNA from carcinogenic human papillomaviruses.
description
2007 nî lūn-bûn
@nan
2007 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի մարտին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
name
PreTect HPV-Proofer: real-time ...... ogenic human papillomaviruses.
@ast
PreTect HPV-Proofer: real-time ...... ogenic human papillomaviruses.
@en
PreTect HPV-Proofer: real-time ...... ogenic human papillomaviruses.
@nl
type
label
PreTect HPV-Proofer: real-time ...... ogenic human papillomaviruses.
@ast
PreTect HPV-Proofer: real-time ...... ogenic human papillomaviruses.
@en
PreTect HPV-Proofer: real-time ...... ogenic human papillomaviruses.
@nl
prefLabel
PreTect HPV-Proofer: real-time ...... ogenic human papillomaviruses.
@ast
PreTect HPV-Proofer: real-time ...... ogenic human papillomaviruses.
@en
PreTect HPV-Proofer: real-time ...... ogenic human papillomaviruses.
@nl
P2093
P1476
PreTect HPV-Proofer: real-time ...... ogenic human papillomaviruses.
@en
P2093
Frank Karlsen
Hanne Skomedal
Irene Kraus
Tor Molden
Trine Nordstrøm
P304
P356
10.1016/J.JVIROMET.2007.01.036
P577
2007-03-26T00:00:00Z